Invention Grant
- Patent Title: Agent for treating nocturnal pollakiuria
-
Application No.: US16768972Application Date: 2018-12-20
-
Publication No.: US11376253B2Publication Date: 2022-07-05
- Inventor: Katsuya Segawa , Takafumi Kurose
- Applicant: KYORIN PHARMACEUTICAL CO., LTD.
- Applicant Address: JP Tokyo
- Assignee: KYORIN PHARMACEUTICAL CO., LTD.
- Current Assignee: KYORIN PHARMACEUTICAL CO., LTD.
- Current Assignee Address: JP Tokyo
- Agency: Wenderoth, Lind & Ponack, L.L.P.
- Priority: JPJP2017-244910 20171221,JPJP2018-212256 20181112
- International Application: PCT/JP2018/047038 WO 20181220
- International Announcement: WO2019/124507 WO 20190627
- Main IPC: A61K31/519
- IPC: A61K31/519 ; A61P13/10 ; A61K9/00
Abstract:
[Problem] To provide a novel therapeutic agent for nocturnal pollakiuria.
[Solution] A therapeutic agent for nocturnal pollakiuria which contains, as an active ingredient, (6S)—N-[4-({(2S,5R)-5-[(R)-hydroxy(phenyl)methyl]pyrrolidin-2-yl}methyl)phenyl]-4-oxo-4,6,7,8-tetrahydropyrrolo[1,2-a]pyrimidine-6-carboxamide.
[Solution] A therapeutic agent for nocturnal pollakiuria which contains, as an active ingredient, (6S)—N-[4-({(2S,5R)-5-[(R)-hydroxy(phenyl)methyl]pyrrolidin-2-yl}methyl)phenyl]-4-oxo-4,6,7,8-tetrahydropyrrolo[1,2-a]pyrimidine-6-carboxamide.
Public/Granted literature
- US20210000831A1 AN AGENT FOR TREATING NOCTURNAL POLLAKIURIA Public/Granted day:2021-01-07
Information query
IPC分类:
